Boston Scientific treats 1st patient in Zero AF trial, aims for FDA win for Blazer catheter
January 16, 2013 by MassDevice staff
Medical device giant Boston Scientific treats the 1st patient in a clinical trial of its Blazer open-irrigated temperature ablation catheter, hoping to use the results to win FDA clearance to treat patients with heart rhythm disorders.
Massachusetts medical device giant Boston Scientific (NYSE:BSX) launched a new study of its Blazer Open-Irrigated Temperature Ablation Catheter, hoping to use the results to win FDA approval.
News Well, Clinical Trials, Ablation, Catheters, Food & Drug Administration (FDA), Research & Development
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
- How to simplify consents
Navigation
NEWS
J&J's Synthes unit wins $16M ruling in patent fight with Globus Medical
A Delaware jury sides with Johnson & Johnson's DePuy-Synthes subsidiary in a patent spat over 3...
Aneurysm: Covidien touts pivotal study on Pipeline embolization device
Results of pivotal study on Covidien subsidiary eV3's Pipeline cerebral aneurysm device, published in...
ForSight Vision5 gets new CEO, closes $9.3M funding round
Delphi Ventures' John Maroney joins ForSight Vision5 as president, CEO & Director as the...
Diabetes: Echo Therapeutics sends pre-submission package to FDA for Symphony needle-free CGM
Echo Therapeutics initiates discussions with the FDA on the regulatory pathway for its Symphony non-...
Real-world results cast doubt on renal denervation for high blood pressure
Study results revealed in Europe this week cast doubt on the efficacy of renal denervation for...
